Doctors are hailing a new way to treat serious asthma and chronic obstructive pulmonary disease attacks that marks the first breakthrough for 50 years and could be a “gamechanger” for patients.
A trial found offering patients an injection was more effective than the current care of steroid tablets, and cuts the need for further treatment by 30%.
The results, published in the Lancet Respiratory Medicine journal, could be transformative for millions of people with asthma and COPD around the world.
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is used as a repeat treatment for severe asthma at a low dose, but the trial found a higher single dose could be very effective if injected at the time of a flare-up.
World-leading scientists have called for a halt on research to create “mirror life” microbes amid concerns...
Providence is now home to the country’s first state-sanctioned facility for people to use illegal drugs...
A federal court in North Dakota has blocked Affordable Care Act (ACA) coverage for immigrants that came...
